Millrace Asset Group, Inc. Exagen Inc. Transaction History

Millrace Asset Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$11.0 - $16.7 $739,585 - $1.12 Million	-67,235 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$12.7 - $25.95 $69,024 - $141,038	5,435 Added 8.79%	67,235 $1.07 Million
Q4 2019 Feb 13, 2020	SELL	$12.61 - $28.48 $103,402 - $233,536	-8,200 Reduced 11.71%	61,800 $1.57 Million
Q3 2019 Nov 14, 2019	BUY	$14.5 - $17.5 $1.02 Million - $1.23 Million	70,000 New	70,000 $1.08 Million

9.08M

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $177M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Millrace Asset Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Millrace Asset Group, Inc. with notifications on news.